Friday, November 05, 2021 – 06:45am
PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid.
Share Article
On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The 3rd CMC-China 2021
Time: September 29-30, 2021
Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China.
Synergy of Centralized China’s Drug Volume-ba...
Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models
This forum focuses on the interdisciplinary and cutting-edge technologies...
President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...